Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06620419 · ClinicalTrials.gov registry record · NA
Clinical Study of External Electrical Stimulation for Male Incontinence
A NA study of Urinary Incontinence, sponsored by Elidah.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06620419: Active NA study of Urinary Incontinence, sponsored by Elidah.
NCT06620419 is a NA study of Urinary Incontinence that is active but no longer recruiting, run by Elidah. The registered enrollment target is 30 participants, below the 261-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06620419, a NA study of Urinary Incontinence, is active but no longer recruiting, sponsored by Elidah.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to evaluate the effectiveness of the Elidah neuromuscular stimulation treatment to reduce incontinence in men post-prostatectomy.
Primary Outcome
24-hr pad weight
Conditions Studied
Interventions
- DEVICE Perineal-applied electrical stimulation
Study Locations (1)
Connecticut
- Elidah - Monroe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-05-15 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What the registry record for NCT06620419 still lists
NCT06620419 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 261-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Urinary Incontinence appearing as the primary indexed condition, and to 1 intervention - of which Perineal-applied electrical stimulation is the first listed.
NCT06620419 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT06620419 about?
NCT06620419 is a clinical study titled "Clinical Study of External Electrical Stimulation for Male Incontinence". The purpose of this research is to evaluate the effectiveness of the Elidah neuromuscular stimulation treatment to reduce incontinence in men post-prostatectomy.
What is the current status of trial NCT06620419?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-05-15. Estimated completion is 2026-06-30.
What conditions does trial NCT06620419 study?
This clinical trial studies the following conditions: Urinary Incontinence.
What interventions are being tested in trial NCT06620419?
The interventions under investigation include: Perineal-applied electrical stimulation (DEVICE).
Who is sponsoring clinical trial NCT06620419?
This trial is sponsored by Elidah, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06620419 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06620419's enrollment target sits among peer trials
30 37th of 48 higher than 11 of 48 other Urinary Incontinence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Incontinence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
-
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
RECRUITING · NA
-
Improving Overactive Bladder Treatment Access and Adherence
RECRUITING · NA
-
Training for Urinary Leakage Improvement After Pregnancy
RECRUITING · NA
-
Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI